CHIRANJEEV SINGH,HEMLATA DEWANGAN,RITU JOON
DOI: https://doi.org/Finding reliable biomarkers from a conveniently accessible source is therefore essential as it could result in reasonably priced assays that are useful for routine screening. An alternative, non-invasive method of improving cancer screening may be offered via blood-based indicators. Many important studies on the creation of screening tools utilizing blood-based biomarkers have surfaced in recent years, despite the fact that none of the biomarkers now available on the market are sensitive enough for the early detection of BC.Blood-based biomarkers for BC screening are still in their infancy, nevertheless, and several preclinical and clinical issues need to be addressed before they can be used in clinical settings. The most current studies on the application of blood-based biomarkers as innovative BC screening methods are compiled in this review, along with the restrictions and difficulties that must be resolved before their application is moved from the bench to the bedside.
